Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Ensure Drug Regimen Free from Unnecessary Antipsychotic Medication

Weslaco, Texas Survey Completed on 05-20-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident’s drug regimen was free from unnecessary drugs, specifically regarding the use of risperidone (Risperdal), an antipsychotic medication. The resident in question was an elderly female with diagnoses including paraplegia, mood disorder, and schizoaffective disorder. Her medical records, including the face sheet and MDS assessment, reflected severe cognitive impairment and the use of antipsychotic and antidepressant medications. The care plan documented the use of Risperdal for symptoms related to schizophrenia, such as mood changes and yelling, and included monitoring for adverse reactions and pharmacy review per facility policy. Upon review, it was found that the medical diagnosis supporting the use of Risperdal was inconsistently documented. While the care plan and some physician notes referenced schizophrenia or schizoaffective disorder, the official medical diagnosis in the resident’s records did not consistently reflect this until the day of the survey. The nurse practitioner and DON confirmed that the diagnosis of schizophrenia was only present in certain notes and the order entered into the electronic charting system, but not in other official paperwork. The diagnosis was added to the medical record on the day of the survey, and the nurse practitioner clarified that the correct diagnosis should be schizoaffective disorder, as originally given by the primary care provider. Interviews with facility staff, including the DON and LVN, revealed that medication orders are entered and double-checked by nursing staff, but if the wrong diagnosis is entered, it could result in an inappropriate medication regimen. The lack of a consistent and adequate indication for the use of Risperdal in the resident’s official medical record led to the finding that the facility failed to ensure the resident’s drug regimen was free from unnecessary drugs.

An unhandled error has occurred. Reload 🗙